Increased circulating interleukin-17 levels in preeclampsia
- 1 November 2015
- journal article
- clinical trial
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 112, 53-57
Abstract
No abstract availableKeywords
Funding Information
- Hungarian Academy of Sciences
- Hungarian Scientific Research Fund (PD 109094)
This publication has 30 references indexed in Scilit:
- Global and regional estimates of preeclampsia and eclampsia: a systematic reviewEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- The predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsiaJournal of Reproductive Immunology, 2012
- Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension arrayBMC Immunology, 2010
- Interleukin‐17 and its target genes: mechanisms of interleukin‐17 function in diseaseImmunology, 2010
- Evidence for distinct preterm and term phenotypes of preeclampsiaThe Journal of Maternal-Fetal & Neonatal Medicine, 2010
- Structure and signalling in the IL-17 receptor familyNature Reviews Immunology, 2009
- Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsiaCell Stress and Chaperones, 2009
- Association between tumor necrosis factor (TNF)-α G-308A gene polymorphism and preeclampsia complicated by severe fetal growth restrictionClinica Chimica Acta, 2008
- A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17Nature Immunology, 2005
- Interleukin 17–producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineagesNature Immunology, 2005